Back to Trades
Devlin Jodi
Chief of Clinical OperationsCIK 0001992151
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Devlin Jodi, Chief of Clinical Operations, has disclosed $568.2K in transactions — all concentrated in TriSalus Life Sciences, Inc. (TLSI). Their disclosed trades are heavily weighted toward selling — $0 in buys and $13.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Mar 20 | TLSI TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Operations | Sell | $13.2K |
| Nov 25 | TLSI TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Operations | Grant | $555.0K |
2 filings